Blood Disorders Current Research

Regular Off Off

The blood disorders research team at North Bristol NHS Trust co-ordinates and supports the delivery of clinical trials across a variety of haematological conditions including, myeloma, lymphoma, leukaemia, myeloproliferative neoplasms (MPNs), and immune thrombocytopenic purpura (ITP).

Our wide portfolio of cancer research makes us one of the largest cancer centres in the South West, with over 200 new blood cancer cases being diagnosed over the last year. Of this total, we currently have over 100 patients taking part in blood cancer trials at North Bristol NHS Trust.

In 2017 NBT was also designated a Myeloma UK Clinical Trials Network Accessory Site. This means that our patients are able to access to drugs that are not currently available on the NHS.

Please speak to the person treating you to find out if there is a research study that may be able to help you.

Current Studies:

COSMOS

Characterising risk and biology Of Smouldering Myeloma for early detection Of Symptomatic myeloma

Study Overview: COSMOS is an observational study which means that there is no drug being tested. You will continue to be followed up regularly by your haematologist in clinic as normal. When you have a blood test or bone marrow test, we will use part of the sample for the study.

For more detailed information please visit the  COSMOS Trial website.

Principal Investigator: Alastair Whiteway 
Planned end date: 30/04/2027
Local Ref: 5754

MITHRIDATE

MITHRIDATE: A phase III, randomised, open-label, Multicenter International Trial comparing ruxolitinib with either HydRoxycarbamIDe or interferon Alpha as first line ThErapy for high risk polycythemia vera

To see more detail about this study please visit  Mithridate - University of Birmingham who are sponsoring this study.

Study Overview: The MITHRIDATE study has been set up to investigate which treatment is most effective for patients who have high risk polycythemia vera (PV). The study will test how safe and effective a drug called ruxolitinib is when treating patients with PV compared to the current Best Available Therapy (BAT).

Principal Investigator: Alastair Whiteway
Planned end date: 01/07/2029
Local Ref: 5188

 

RADAR (UK-MRA Myeloma XV)

RADAR (UK-MRA Myeloma XV) is a clinical trial for newly diagnosed multiple myeloma patients who are suitable for a stem cell transplant. The trial will investigate precision medicine approaches to allocate treatment to patients based on the genetics of their myeloma and the patient’s response to initial treatment. Some patients have been found to have particular genetic abnormalities in the myeloma cells, and these ‘high risk’ patients do not respond well to standard treatment. It has also been found that some patients who don’t have these genetic abnormalities (‘standard-risk’) may not respond to initial therapy as well as others. This study will investigate treatment combinations for these two groups of patients. This study will also investigate whether a third group of patients, those who are standard-risk and also respond well to initial treatment, can receive treatment for a shorter period of time without coming to any harm.

Project Details
Principal Investigator: Dr Alastair Whiteway
Planned End Date: end 2025
Local Ref: 3959

STATIC

STATIC

A Randomised Phase III Trial Comparing Intermittent with Continuous Treatment Strategies in Chronic Lymphocytic Leukaemia (CLL)

For more detailed information please visit the   STATIC Clinical Trial • CTRU Leeds Research Portal 

Study Overview: STATIC is a clinical trial to find out whether people with Chronic Lymphocytic Leukaemia (CLL) who have had a good response to ibrutinib or acalabrutinib can take a break from treatment, and only restart treatment if the CLL comes back. Therefore, we are comparing whether having a break from treatment with ibrutinib or acalabrutinib will work as well as continuing treatment without a break.

We will also test whether taking a break from treatment reduces side effects, whether it lowers the risk of CLL becoming resistant to ibrutinib or acalabrutinib, and whether there is any difference in the overall cost of CLL treatment. We also want to know whether having a break from ibrutinib or acalabrutinib changes how participants are feeling emotionally, and what they like and do not like about having treatment which includes breaks.

Principal Investigator: Dr Jaroslaw Sokolowski
Planned end date: 01/05/2032
Local Ref: 5122

 

Other Cancer Studies:

Identifying and validating molecular targets in nervous system tissue (IVMBT)

Currently benign and malignant brain tumours are treated by surgery or radiation therapy plus or minus chemotherapy. The aim of the study is to discover and validate new molecular biomarkers and drug targets for brain tumours using laboratory research and comparing the findings with control tissue.

This includes also using tissues, blood fractions and cell culture from patients with brain tumours. We hope that in vitro research will reveal biomarkers for these tumours which in the future could indicate successful drug action or are specific for a genetic subtype of tumour. In addition, we hope that these biomarkers could aid early diagnosis of central nervous system (CNS) tumours.

Project Details
Principal Investigator: Dr Kathreena Kurian
Planned End Date: 20/07/2024
Local Ref: 4626

Take Part in Research

Patient & Doctor viewing an x-ray

Become one of the thousands of people taking part in research every day within the NHS.

About Research & Development

NBT Researcher

Find out more about our research and how we're working to improve patient care.

Contact Research

Research & Development
North Bristol NHS Trust
Level 3, Learning & Research building
Southmead Hospital
Westbury-on-Trym
Bristol, BS10 5NB

Telephone: 0117 4149330
Email: research@nbt.nhs.uk

Cancer
R&I Cancer.png

Tuberculosis

Regular Off Off

Tuberculosis (TB) TB services in Bristol, North Somerset and South Gloucestershire are provided in partnership with the Bristol Royal Infirmary. Clinics operate at both hospitals, supported by a multidisciplinary team of specialist TB nurses and a pharmacist.

Referrals for assessment for latent TB can be made routinely via the NHS electronic referrals system. Patients thought to have possible active TB should be referred urgently via eRS and a highlighted by a phone call to our secretary – we aim to see such cases within 1 week.

Hospitals referring complex or resistant TB should speak to the ID registrar on call via switchboard on 0117 9505050.

We have excellent links with other specialist teams to provide comprehensive management for TB inpatients and outpatients.

For more information about TB visit www.tbalert.org.

Feedback

Thank you for seeing me so quickly & sorting me out

Professor Emma Clark - Rheumatology & Osteoporosis

Regular Off On A-Z of Consultants

Dr Emma ClarkGMC Number: 4304423

Year of first qualification: 1996

Specialty: Rheumatology & Osteoporosis

Clinical interests: General rheumatology, osteoporosis, metabolic bone disease

Secretary: Jessica Goodwin

Telephone: 0117 414 2849

Professor Emma Clark is active across all adult general rheumatology services.

Professor Clark has a particular clinical interest in osteoporosis and hypermobility. She runs a dedicated osteoporosis/metabolic bone disease clinic.

She leads on the vertebral fracture assessment (VFA) component of the DXA service.

She is also an active researcher through her post as Reader in Rheumatology, Bristol Medical School, University of Bristol. She runs three research programmes: vertebral fractures, scoliosis and hypermobility.
 

Clark

BUI Research Team

Regular Off Off

Urology Clinical Research Lead

Jonathan Aning, Consultant Urological Surgeon. 
 

Researchers

Professor Paul Abrams, Consultant Urological Surgeon.
Professor Nikki Cotterill, Professor in Continence Care.
Anne Fee, Specialist Clinical Researcher
Andrew Gammie, Clinical Engineer
Kathryn Jones, Research Associate
Nicola Morris, Laboratory Research Manager
Alan Uren, Specialist Clinical Researcher

Research Nurses

Rebecca Cousins, Lead Urology Research Nurse
Marta Cobos-Arrivabene, Urology Research Nurse
Victoria Garner, Urology Research Nurse
Caroline Jones, Urology Research Nurse

 

Support BUI

We need your support to help give more people in Bristol and the South West the very best urological care here at the BUI. We are part of Southmead Hospital Charity and there are a number of ways you can help. Visit their website www.southmeadhospitalcharity.org.uk

 

BUI Clinical Team

Regular Off Off

 

BUI Clinical Team

Consultants


Aditya Manjunath (Clinical Lead)
Salah Albuheissi
Jonathan Aning
Stefanos Bolomytis
Helena Burden
Hugh Gilbert
Andrew Harris
Hashim Hashim
Motaz Hassan
Odunayo Kalejaiye
Frank Keeley
Anthony Koupparis
Su-Min Lee
Ahmed Mahrous
Caroline Ochoa Vargas
Raj Pal
Joe Philip
Farukh Qureshi
Edward Rowe
Ala'A Sharaf
Anthony Timoney
Tim Whittlestone
Zsuzsanna Zotter

 

Cancer Nurse Specialists

Amy Hadley (Team Leader)
Helen Chilcott
Sarah Fletcher

 

Clinical Urology Nurse Practitioner

Jasmine King

Urodynamics & Functional Urology Team

Professor Hashim Hashim (Director)
Carolina Ochoa Vargas
Ala'a Sharaf
Alex Bacon
Connie Chew (Nurse)
Dr Andrew Gammie (Clinical Scientist)
Anna Hassine
Shiby Priju (Nurse)
Dr Laura Thomas (Urodynamics Manager)
Rachel Tindle (Clinical Scientist)

 

Consultant Oncologists

Amit Bahl
Amar Chalapalli
Susie Masson
 

Support BUI

We need your support to help give more people in Bristol and the South West the very best urological care here at the BUI. We are part of Southmead Hospital Charity and there are a number of ways you can help. Visit their website www.southmeadhospitalcharity.org.uk

 

Prostate Disease

Regular Off Off

Prostate disease is the term uses to describe conditions that can affect the prostate gland.

These can be:

  • prostate enlargement
  • inflammation of the prostate gland (prostatitis) 
  • prostate cancer 

Prostate enlargement

Prostate enlargement is a common condition especially in around a third of men over the age of 50.

If the prostate becomes enlarged it can put pressure on the urethra (a tube that runs from the bladder through the prostate) and make is difficult to pass urine

Symptoms of an enlarged prostate

  • difficulty when starting to urinating
  • weak flow of urine
  • having to strain to pass urine
  • peeing more frequently
  • having to get up and pee at night

In the first instance it’s recommended that you reduce the amount you drink before bed to see if that eases the symptoms.
Medications, such as alpha blockers, are available to help reduce the size of the prostate and relax the prostate gland muscles.

Only if medication doesn’t ease the problems is surgical intervention an option. The inner part of the prostate gland that’s causing the blockage is surgically removed.

Find out more about prostate enlargement.

Prostatitis

Prostatitis is a condition where the prostate gland becomes inflamed. This can occur as a result of an infection although in most cases no evidence of infection is found.

Symptoms of prostatitis include:

  • pelvic pain
  • testicular pain
  • pain when urinating (usually associated with a urinary tract infection)
  • pain when ejaculating semen
  • pain in the perineum (the area between the anus and back of the scrotum). This can be worse when sitting.

Prostatitis is treated by a combination of painkillers and medication known as an alpha-blocker.

Find out more about prostatitis.

Urinary Incontinence & Bladder Problems

Regular Off Off

Firstly, the most important thing to note is that everyone with a bladder problem can be helped and many can be cured.

Urinary incontinence is the  release of urine unwillingly. It can affect both men and women and there are a number of reasons for this and there are also a number of ways it can be treated or managed.

The Continence and Urodynamics Unit at the Bristol Urological Institute (BUI), is a centre of excellence with a national and international reputation in the assessment and treatment of  urinary incontinence. The unit offers secondary and tertiary regional, national and international services for urinary incontinence. Urinary incontinence comes under the umbrella of female urology, neurourology and urodynamics, often termed functional urology.

Clinicians, specialists nurses, continence advisors and physiotherapists come together to run a dedicated incontinence clinic at the BUI.

The service is led by a team of three clinical experts, Prof Paul Abrams, Prof Marcus Drake and Mr Hashim Hashim, who have gained an international reputation for their dedication into developing new diagnostic tools, treatments and devices to help those suffering from what was seen as, until recently, a taboo and unmanageable disease.

Types of Urinary Incontinence

Stress incontinence
This type of incontinence actually does not have anything to do with emotional stress but is related to pressure to the bladder such as being overweight, pregnancy, sneezing, lifting heavy objects, exercise and some medical conditions. Leakage is due to a weakness of the pelvic floor that supports the bladder and the urethra. It is often termed ‘ effort’ incontinence.

Treatments for stress incontinence in women
Non-surgical treatments include:

  • Restricting fluid intake
  • Stopping smoking
  • Reducing weight
  • Pelvic floor exercises
  • Medications such as Duloxetine

For more information about these treatments visit www.nhs.uk/Conditions/Incontinence-urinary/Pages/Treatment.aspx

For 1 in every 3 women with symptoms of stress incontinence these non-operative treatments can make symptoms much better or cure them completely.

Surgical Treatments for Stress Incontinence at BUI
Surgical treatments include:

  • Injection/Bulking agent treatment
  • Sling procedures (Natural and Synthetic)
  • Colposuspension
  • Artificial Urinary Sphincter

For more information about these treatments visit www.nhs.uk/Conditions/Incontinence-urinary/Pages/Treatment-surgical.aspx

Operations for stress incontinence depend on supporting the urethra. There are several  operations to cure this type of leakage, and the BUI is one of the few centres in the United Kingdom that can offer all these treatments. According to the National Institute of Clinical and Health Excellence (NICE), women with stress incontinence should be offered all forms of treatment and not restricted to one type. NICE also recommend that women are discussed in a multidisciplinary team meeting. The surgeons at the BUI are also experts in dealing with tape complications and are the regional centre for such treatments.

Stress Incontinence in Men
The most common reason for men having stress incontinence is due to treatment for prostate cancer. Surgery and radiotherapy can weaken pelvic floor muscles and the urethral sphincter (a ring of muscle that keeps the urethra closed)

Non-surgical treatments include:

  • Pelvic floor muscle training (PGMT)
  • Bladder retraining
  • Medicines

Surgical treatments include:

  • Artificial sphincter
  • Male Sling
  • Urethral bulking
  • Penile clamp

For more information about these treatments visit www.nhs.uk/Conditions/Incontinence-urinary/Pages/Treatment-surgical.aspx

Urgency incontinence and overactive bladder (OAB) syndrome
This type of incontinence is characterized by a strong urge to urinate with no ability to stop it and often leads to leaking before reaching the toilet in time. It can affect about 12% pf the population with no known cause or it can be caused by as a result of an injury to nerves or muscles which help control urinary flow but it can also be caused by some medical conditions.

The doctor/nurse will ask you questions about the problem and your general health. He/she may do a physical external examination, perform an internal examination and a urine test will be done to check for infection. You will be asked to complete a 3-day frequency/volume chart to record the time of voiding and volumes of urine passed. A flow test may also be performed. This is a test which involves passing urine into a special machine to measure the strength of flow and to check whether the bladder has emptied completely.

If the symptoms fail to respond to conservative and medical treatment a more invasive investigative test may be performed called urodynamics. This is a special test to measure pressures inside the bladder.

Treatments:

  • Change of drinking habits
  • Bladder training
  • Medication
  • Surgery

Surgery for Overactive Bladder
The surgeons at the BUI are the only centre in the South West of England that can offer all forms of treatment for refractory overactive bladder syndrome including Botox injection in the bladder, Sacral nerve stimulation, and major surgery.

Pelvic Organ Prolapse
Mr Hashim is one of a few urologists in the United Kingdom who is fellowship trained in pelvic organ prolapse repair in women and also works closely with urogynaecologists and colorectal surgeons at Southmead Hospital to offer a first-class service for women with prolapse.

Pelvic organ prolapse is the bulging of one or more of the pelvic organs (uterus, vagina and bowel) into the vagina. Pelvic organ prolapse can affect the front, top or back of the vagina.

Symptoms are:

  • the sensation (feeling) of something coming down or protruding of the vagina
  • discomfort during sex
  • problems passing urine 

Some women with a pelvic organ prolapse don't have any symptoms and it’s only discovered during an internal examination such as a cervical screen.

Pelvic organ prolapse isn't life-threatening, but it can affect your quality of life.

The main types of prolapse are:

  • anterior prolapse (cystocele) – where the bladder bulges into the front wall of the vagina
  • prolapse of the uterus and cervix or top of the vagina – which can be the result of previous treatment to remove the womb
  • posterior wall prolapse (rectocoele or enterocoele) – when the bowel bulges forward into the back wall of the vagina

It's possible to have more than one of these types of prolapse at the same time.

Genito-urinary Fistula
A fistula is an abnormal communication between the bladder and the vagina or the urethra and the vagina. This causes women to leak continuously. The BUI surgeons are trained in vaginal and abdominal vesico-vaginal and urethro-vaginal fistula repairs and offer a regional and tertiary service for such repairs.

Andrology

Regular Off Off

BUI Andrology

Andrology & Male Urethral Reconstruction

Andrology is a subsection of Urology which deals with problems affecting the male reproductive system. These conditions may present as emergencies or through our outpatient clinics.

We currently have an experienced team of 4 consultants and a senior specialist Andrology nurse with over 15 years of experience.

We provide care for the whole or Bristol and act as a tertiary referral centre for South-West England.

We also have a long tradition of research following on from the Dr Gingell who did the original UK research on Viagra.

In addition, we have had 4 MDs in collaboration with the cardiac institute researching the various factors causing erectile dysfunction.

Andrology Team


Prof Raj Persad
Mr Salah Al-buhessi
Mr David Dickerson
Mr Rupert Beck
Miss Wendy Hurn

We manage the following conditions:

Priapism
This is an abnormal prolonged erection which requires emergency treatment.

Penile fracture
This is due to a tear in the lining (tunica albuginea) of the penile erectile apparatus. This requires emergency surgical treatment.

Torsion
This is a twist in the tube from which the testis is suspended (spermatic cord). This results in the blood supply to the testis being cut off. It requires emergency surgery to untwist the spermatic cord rapidly or it results in loss of the testis.

Genito-urinary trauma

Erectile dysfunction
This is an inability to either develop or sustain an erection sufficient for sexual intercourse. It is common and often very distressing. It may be due to medical conditions such as diabetes or following surgery for cancer.

Ejaculatory disorders including premature ejaculation
This is an abnormality of the expulsion of semen. It is a very distressing condition and is probably the most common sexual dysfunction in men.

Penile curvature
This condition is either present lifelong (congenital penile curvature) or may develop over time (Peyronie’s disease). Peyronie’s disease is due to scarring of the tunica albuginea thereby creating a plaque.

Urethral stricture disease
This is a scarring condition of the male waterpipe (urethra). This results in difficulty passing urine and emptying the bladder.

We also offer the following treatments:

  • Penile prosthesis
    This may be inserted electively or as an emergency. The indications are for end stage erectile dysfunction, prolonged priapism or severe penile curvature associated with erectile dysfunction.
  • Surgery for penile curvature
    This is either a Nesbitt’s plication or a Lue procedure. The aim of both procedures is to create a straight and functional penis. Nesbitt’s involves the excision of part of the penile tissue. A Lue involves incision of the Peyronie’s plaque and the insertion of a graft.
  • Urethroplasty
    This is the excision and repair of the urethra which has been affected by stricture disease. This may involves the insertion of a graft.
  • Penectomy and penile reconstruction
    This is the excision of some or all of the penis due to cancer. Where only part of the penis has been removed, we also offer surgery to re-fashion the penis so it looks as close to normal as possible. This is penile reconstruction. Penile reconstruction may also be offered where the penis or foreskin has been affected by non-cancerous conditions.

Men with non-emergency conditions may be referred to us via their GP through NHS eReferrals to our andrology clinics either at Southmead or at South Bristol.

Useful Links

Sexual Advice Association: www.sda.uk.net
NHS UK: www.nhs.uk/livewell/goodsex